Navigation Links
Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day
Date:10/21/2009

INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- More than 25 Eli Lilly and Company (NYSE: LLY) facilities around the world today will celebrate "Energy Day," which is a new corporate sustainability effort designed to educate Lilly employees about the company's latest energy reduction goals and to encourage sustainable behaviors.

Lilly reached the energy goal it previously set two years early. Over a five-year period, from 2004 to 2008, Lilly has:

  • Improved energy intensity (in energy used per dollar of sales) by more than 35 percent and reduced absolute energy use by 5.8 percent
  • Cut absolute greenhouse gas emissions by 4.4 percent

Lilly's new goal for the year 2013 is to improve energy efficiency and reduce the corresponding greenhouse gas emissions by 15 percent. In order to meet its goal, the company is pursuing energy efficiency projects and engaging employees to identify opportunities for continued improvement.

"Lilly is committed to making high-quality medicines responsibly, which includes minimizing our natural resource use and lessening our impact on the environment," said Greg Spratt, advisor of environmental sustainability at Lilly. "Our employees are eager to become more engaged and involved in protecting our environment, and we are leveraging that commitment in order to help the company meet its aggressive energy goal."

Since 2006, the company has invested $23 million in energy and waste reduction projects across the globe. Upon completion of these projects, Lilly estimates that it will save 640,000 mm BTUs of energy and reduce its greenhouse gas emissions by nearly 85,000 metric tons - the equivalent of the electricity used by 11,789 homes in one year and the amount of greenhouse gas emissions generated by burning 444 railcars of coal.

Lilly's global sites will celebrate Energy Day in a variety of ways, including increased use of public transportation for commuting, interactive exhibits, and contests for generating new energy saving ideas. Employees working at Lilly's corporate headquarters in Indianapolis will have an opportunity to tour one of the two "green roofs" that were recently installed as pilot sustainability projects to improve the energy efficiency of the building and to reduce storm water run-off.

Lilly's energy reduction efforts are part of the company's overall environmental goals, which also include aggressive reductions in water intake (25 percent) and waste to landfill (40 percent). More information about Lilly's sustainability goals can be found at http://www.lilly.com/responsibility/health/.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

CR-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
2. Lilly Declares Fourth-Quarter Dividend
3. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
4. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
5. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
6. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
7. Study Showed Lillys GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
8. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
9. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
10. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
11. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... , May 20, 2016 ... Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant Coagulation ... Biological Drugs - This New Study Reveals Selling ... Ahead ,What is the future ... the latest technological and commercial analysis. Staying ahead ...
(Date:5/19/2016)... PARIS , May 19,2016 ... Activities at Digestive Disease Week Meeting and 91 ... Society Mauna Kea Technologies (Euronext: MKEA, ... laser endomicroscopy platform, today announced that its Cellvizio ... meeting focused on gastroenterology during the month of ...
(Date:5/19/2016)... , May 19, 2016 BioLight ... an emerging global ophthalmic company focused on the discovery, ... address ophthalmic conditions, announced today that it has obtained ... ) for the manufacturing, distribution, marketing and sales ... treatment of dry eye syndrome (DES) and other ophthalmic ...
Breaking Medicine Technology:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... On the ... took the time to summarize the weight loss process: , New patients have a ... Composition Analysis (BCA) to get accurately evaluated. , Body Composition Analysis, There are 15 ...
(Date:5/23/2016)... , ... May 23, 2016 , ... According to an ... that, less than 1% of United Kingdom residents who could benefit from bariatric surgery ... Service (NHS) increases the number of bariatric procedures it offers to obese patients from ...
(Date:5/23/2016)... ... May 23, 2016 , ... The ... high-level representatives from the Japan PMDA, US FDA, industry and academia at the ... standards help format data from clinical trials so that it can be shared ...
(Date:5/23/2016)... ... May 23, 2016 , ... In light of ... reminds pet owners that intervening at the first sign of their pet overheating ... normal body mechanisms cannot keep the body’s temperature within a safe range. Considered ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... in research on discriminated minorities’ quality of life and is currently focusing on ... creating advocacy documentaries to be tested through research to find out whether watching ...
Breaking Medicine News(10 mins):